Abstract

Inflammation regulates neurogenesis, and the brains of patients with schizophrenia and bipolar disorder have reduced expression of neurogenesis markers in the subependymal zone (SEZ), the birthplace of inhibitory interneurons. Inflammation is associated with cortical interneuron deficits, but the relationship between inflammation and reduced neurogenesis in schizophrenia and bipolar disorder remains unexplored. Therefore, we investigated inflammation in the SEZ by defining those with low and high levels of inflammation using cluster analysis of IL6, IL6R, IL1R1 and SERPINA3 gene expression in 32 controls, 32 schizophrenia and 29 bipolar disorder cases. We then determined whether mRNAs for markers of glia, immune cells and neurogenesis varied with inflammation. A significantly greater proportion of schizophrenia (37%) and bipolar disorder cases (32%) were in high inflammation subgroups compared to controls (10%, p < 0.05). Across the high inflammation subgroups of psychiatric disorders, mRNAs of markers for phagocytic microglia were reduced (P2RY12, P2RY13), while mRNAs of markers for perivascular macrophages (CD163), pro-inflammatory macrophages (CD64), monocytes (CD14), natural killer cells (FCGR3A) and adhesion molecules (ICAM1) were increased. Specific to high inflammation schizophrenia, quiescent stem cell marker mRNA (GFAPD) was reduced, whereas neuronal progenitor (ASCL1) and immature neuron marker mRNAs (DCX) were decreased compared to low inflammation control and schizophrenia subgroups. Thus, a heightened state of inflammation may dampen microglial response and recruit peripheral immune cells in psychiatric disorders. The findings elucidate differential neurogenic responses to inflammation within psychiatric disorders and highlight that inflammation may impair neuronal differentiation in the SEZ in schizophrenia.

Details

Title
A schizophrenia subgroup with elevated inflammation displays reduced microglia, increased peripheral immune cell and altered neurogenesis marker gene expression in the subependymal zone
Author
North, Hayley F 1 ; Weissleder Christin 2   VIAFID ORCID Logo  ; Fullerton, Janice M 3   VIAFID ORCID Logo  ; Sager, Rachel 4 ; Webster, Maree J 5   VIAFID ORCID Logo  ; Weickert, Cynthia Shannon 6 

 Neuroscience Research Australia, Sydney, Australia (GRID:grid.250407.4) (ISNI:0000 0000 8900 8842); University of New South Wales, School of Psychiatry, Faculty of Medicine, Sydney, Australia (GRID:grid.1005.4) (ISNI:0000 0004 4902 0432) 
 Neuroscience Research Australia, Sydney, Australia (GRID:grid.250407.4) (ISNI:0000 0000 8900 8842) 
 Neuroscience Research Australia, Sydney, Australia (GRID:grid.250407.4) (ISNI:0000 0000 8900 8842); University of New South Wales, School of Medical Sciences, Faculty of Medicine, Sydney, Australia (GRID:grid.1005.4) (ISNI:0000 0004 4902 0432) 
 Upstate Medical University, Department of Neuroscience and Physiology, Syracuse, USA (GRID:grid.411023.5) (ISNI:0000 0000 9159 4457) 
 Stanley Medical Research Institute, Laboratory of Brain Research, Rockville, USA (GRID:grid.453353.7) (ISNI:0000 0004 0473 2858) 
 Neuroscience Research Australia, Sydney, Australia (GRID:grid.250407.4) (ISNI:0000 0000 8900 8842); University of New South Wales, School of Psychiatry, Faculty of Medicine, Sydney, Australia (GRID:grid.1005.4) (ISNI:0000 0004 4902 0432); Upstate Medical University, Department of Neuroscience and Physiology, Syracuse, USA (GRID:grid.411023.5) (ISNI:0000 0000 9159 4457) 
Publication year
2021
Publication date
2021
Publisher
Nature Publishing Group
e-ISSN
21583188
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2610236489
Copyright
© Crown 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.